重组抗原疫苗（recombinant antigen vaccine）
举一反三
- Q8-Which of the following proposals are true? A: 1- The new viral recombinant vaccine expressing antigen 85A is efficient in human clinical trials B: 2- Several vaccine candidates based on MVA (Modified Virus Ankara) are protective in human clinical trials C: 3- The recombinant MVA vaccine expressing antigen 85A is protective in pre-clinical tests
- The vaccine for measles is best characterized by() A: Bacteriocin B: Killed virus vaccine C: Inactivated virus vaccine D: Live virus vaccine E: Recombinant virus vaccine
- 重组抗原疫苗:
- 利用DNA重组技术制备的只含保护性抗原的纯化疫苗称为 A: DNA疫苗 B: 合成肽疫苗 C: 结合疫苗 D: 重组抗原疫苗 E: 重组载体疫苗
- 重组乙型肝炎病毒表面抗原疫苗属于 () A: 灭活疫苗 B: 合成肽疫苗 C: 结合疫苗 D: 亚单位疫苗 E: 重组抗原疫苗